International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 180-187 , 1 May 2010

Prognostic Significance of Number of Positive Nodes: A Long-Term Study of One to Two Nodes Versus Three Nodes in Breast Cancer Patients

Presented in part at the European Society of Therapeutic Radiology and Oncology, Gothenburg, Sweden, September, 2008.

  • Patricia Tai, M.B., F.R.C.P.C.

      Affiliations

    • Department of Radiation Oncology, Allan Blair Cancer Center, University of Saskatchewan, Saskatoon, SK, Canada
    • Corresponding Author InformationReprint requests to: Patricia Tai, M.B., F.R.C.P.C., Department of Radiation Oncology, Allan Blair Cancer Center, 4101 Dewdney Ave., Regina, SK S4T 7T1 Canada. Tel: (306) 766-2288; Fax: (306) 766-2845
    • ,
  • Edward Yu, Ph.D., M.D., F.R.C.P.C.

      Affiliations

    • Radiation Oncology Program, London Regional Cancer Center, University of Western Ontario, London, ON, Canada
    • ,
  • Kurian Joseph, M.B., F.R.C.P.C.

      Affiliations

    • Department of Oncology, Cross Cancer Center, University of Alberta, Edmonton, AB, Canada

Received 7 February 2009 ,Revised 25 March 2009 ,Accepted 16 April 2009.

References 

  1. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  2. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol. 1987;5:1546–1555
  3. McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg. 1986;73:264–266
  4. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Eng J Med. 1997;337:956–962
  5. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–955
  6. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  7. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82:247–253
  8. Tai P, Joseph K, Sadikov E, et al. Nodal ratios in node-positive breast cancer—Long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:662–666
  9. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 5th ed.. New York: Wiley-Liss; 1997;p. 123–130
  10. Marks LB, Zeng J, Prosnitz LR. One to three versus four or more positive nodes and postmastectomy radiotherapy: Time to end the debate. J Clin Oncol. 2008;26:2075–2077
  11. Vinh-Hung V, Storme G. No nodal cutoff in node-positive breast cancer women treated with mastectomy. Breast Cancer Res Treat. 2006;98:173–178
  12. Truong PT, Vinh-Hung V, Cserni G, et al. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer. 2008;44:1670–1677
  13. Wilson JF. The breast. In:  Cox JD editors. Moss' radiation oncology: Rationale, technique, results. 6th ed. St. Louis: Mosby-Year Book; 1994;p. 362
  14. Wong JS, O'Neill A, Recht A, et al. The relationship between lymphatic vessel invasion, tumor size, and pathologic nodal status: Can we predict who can avoid a third field in the absence of axillary dissection?. Int J Radiat Oncol Biol Phys. 2000;48:133–137
  15. Galper S, Recht A, Silver B, et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0–3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys. 1999;45:1157–1166
  16. Fowble B, Solin LJ, Schultz DJ, et al. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys. 1989;17:703–710
  17. Haffty BG, Fischer D, Fischer JJ. Regional nodal irradiation in the conservative treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1990;19:859–865
  18. Mehta K, Haffty BG. Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1996;35:679–685
  19. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: A review. Cancer. 1995;76:1491–1512
  20. Halverson KJ, Taylor ME, Perez CA, et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol. 1994;17:461–466
  21. Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 1993;26:593–599
  22. Reed DR, Lindsley SK, Mann GN, et al. Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2005;61:358–364
  23. Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51:671–678
  24. Orecchia R, Huscher A, Leonardi MC, et al. Irradiation with standard tangential breast fields in patients treated with conservative surgery and sentinel node biopsy: Using a three-dimensional tool to evaluate the first level coverage of the axillary nodes. Br J Radiol. 2005;78:51–54
  25. McCormick B, Botnick M, Hunt M, et al. Are the axillary lymph nodes treated by standard tangent breast fields?. J Surg Oncol. 2002;81:12–16
  26. Taghian AG, Bryant J, Anderson S, et al. Pattern of regional failure in patients with breast cancer treated by lumpectomy, breast radiation with or without chemotherapy and/or tamoxifen with no regional radiation: Results from 10 NSABP randomized trials. [Abstract] Int J Radiat Biol Phys. 2003;27S:75a
  27. Stranzl H, Ofner P, Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control?. Strahlenther Onkol. 2006;182:583–588
  28. Reddy SG, Kiel KD. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation. Breast J. 2007;13:12–18
  29. Wang CW, Kuo WH, Chang KJ, et al. Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment?. J Surg Oncol. 2007;96:144–150
  30. Recht A, Siddon RL, Kaplan WD, et al. Three-dimensional internal mammary lymphoscintigraphy: Implications for radiation therapy treatment planning for breast cancer. Int J Radiat Oncol Biol Phys. 1988;14:477–481
  31. Freedman GM, Fowble BL, Nicolaou N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?. Int J Radiat Oncol Biol Phys. 2000;46:805–814
  32. Haffty BG, Buchholz TA, Perez CA. Early stage breast cancer. In:  Helperin EC,  Perez CA,  Brady LW editor. Perez and Brady's principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008;p. 1228–1229
  33. Available from: http://www.ctg.queensu.ca/NCIC CTG trial: MA-20 protocol. Accessed.
  34. Handley R. Carcinoma of the breast. Ann R Coll Surg Engl. 1975;57:59
  35. Yu J, Li G, Li J, et al. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys. 2005;61:874–878
  36. Obedian E, Haffty BG. Internal mammary nodal irradiation in conservatively-managed breast cancer patients: Is there a benefit?. Int J Radiat Oncol Biol Phys. 1999;44:997–1003
  37. Fowble B, Hanlon A, Freedman G, et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 2000;47:883–894
  38. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed.
  39. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2004;22:4247–4254
  40. Truong PT, Lesperance M, Culhaci A, et al. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys. 2005;62:175–182
  41. Truong PT, Jones SO, Kader HA, et al. Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:357–364
  42. Cheng JC, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1–3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:980–988

 Supported by a research grant awarded from the Saskatchewan Cancer Agency.

 Conflict of interest: none.

PII: S0360-3016(09)00671-3

doi: 10.1016/j.ijrobp.2009.04.073

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 180-187 , 1 May 2010

Article Tools

* Image Usage & Resolution